Marked increase of normal blast morphologically mimicking leukemic clone in acute lymphoblastic leukemia patient following G-CSF therapy.
Imataki
Osamu
O
Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa, 761-0793, Japan. oima@med.kagawa-u.ac.jp.
Ohnishi
Hiroaki
H
Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa, 761-0793, Japan.
Yamaoka
Genji
G
Department of Laboratory Medicine, Kagawa University Hospital, Kagawa, Japan.
Arai
Takeshi
T
Department of Laboratory Medicine, Kagawa University Hospital, Kagawa, Japan.
Kitanaka
Akira
A
Department of Laboratory Medicine, Faculty of Medicine, Kagawa University, Kagawa, Japan.
Kubota
Yoshitsugu
Y
Department of Transfusion Medicine, Faculty of Medicine, Kagawa University, Kagawa, Japan.
Ishida
Toshihiko
T
Department of Internal Medicine, Faculty of Medicine, Kagawa University, Kagawa, Japan.
Tanaka
Terukazu
T
Environmental Health Sciences, Faculty of Medicine, Kagawa University, Kagawa, Japan.
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D003561:Cytarabine / Q000008:administration & dosage; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage*; D006801:Humans; D008213:Lymphocyte Activation / Q000187:drug effects*; D008214:Lymphocytes / Q000473:pathology*; D008727:Methotrexate / Q000008:administration & dosage; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000097:blood / Q000188:drug therapy* / Q000473:pathology*; D020127:Recovery of Function / Q000187:drug effects; D012074:Remission Induction; D013997:Time Factors
D003561:Cytarabine; D016179:Granulocyte Colony-Stimulating Factor; D008727:Methotrexate